Katayama, Hiroyuki
Tsou, Peiling
Kobayashi, Makoto
Capello, Michela
Wang, Hong
Esteva, Francisco
Disis, Mary L.
Hanash, Samir
Funding for this research was provided by:
UT | University of Texas MD Anderson Cancer Center
Article History
Received: 5 September 2018
Accepted: 4 March 2019
First Online: 2 April 2019
Competing interests
: M.L.D. has an ownership interest with University of Washington over $10,000 and consultant positions with VentiRX, Roche, BMS, EMD, Serono and Immunovaccine. The authors declare no competing interests.